
- Alfred P. Sloan Foundation
- Research to Prevent Blindness
- Project ALS inc.
- Charles H. Revson Foundation
- Christopher Reeve Foundation
- Croucher Foundation of Hong Kong
- DANA Foundation
- EJLB Foundation
- European Molecular Biology Organization
- Fight For Sight, Inc.
- Fondation pour la Recherche Medicale (France)
- Foundation For The National Institutes of Health
- The Gatsby Charitable Foundation
- G. Harold & Leila Y. Mathers
- Goldman Philanthropic Partnerships
- Helen Hay Whitney Foundation
- Howard Hughes Medical Institute
- Human Frontier Science Program
- Institute for Study of Aging
- James S. McDonnell Foundation
- Johnson & Johnson
- Keck Foundation
- Klingenstein Foundation
- Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF)
- Marubeni International
- Max Kade Foundation, Inc.
- McKnight Endowment Fund
- Merck Foundation
- Muscular Dystrophy Association, Inc.
- National Alliance for Autism Research
- National Alliance for Research Grants to Columbia
- National Association for Research in Schizophrenia and Depression
- National Institute of Aging
- ALS Association
- National Institute of Environmental Health Sciences
- National Institute of Health
- National Institute of Neurological Disorders and Stroke
- New York State Office of Science, Technology and Academic Research (NYSTAR)
- Sackler Laboratories for Developmental Psychobiology
- Simons Foundation
- Southern Consortium for Injury Biomechanics
- Spinal Muscle Atrophy Foundation
- Vision of Children Foundation / John Alden Trust
- Wellcome Trust (England)
- Alzheimer
- Whitehall Foundation
- Louis and Rose Klosk Foundation
- Wings over Wall Street / Muscular Dystrophy Association
- American Academy of Neurology
- American Foundation for Suicide Prevention
- American Heart Association
- Brain Trust
Research to Prevent Blindness (RPB) is the leading non-government supporter of eye research directed at the prevention, treatment or eradication of all diseases that threaten vision
The Project A.L.S./ Jenifer Estess Laboratory for Stem Cell Research (Project A.L.S. Lab) is a joint venture between Project A.L.S. and Columbia University.
Based in New York, theProject A.L.S. Lab does not accept federal funding and has an “open-door” policy that encourages Project A.L.S.-funded stem cell researchers and collaborators from Harvard University, Johns Hopkins University, the Salk Institute, Memorial Sloan-Kettering Cancer Center, and other New York-based institutions to collaborate with Columbia University-based scientists and clinicians.The Charles H. Revson Fellowship offers a unique opportunity for self-development in mid-career for urban leaders who have made a substantial contribution to New York City.
Revson Fellows take a year of study and reflection at Columbia University. They receive financial support and tuition benefits, academic guidance, and access to University libraries and resources. Fellows also participate in weekly seminars to enhance their understanding of the complex challenges facing New York City.Each year, the program selects ten Fellows of diverse backgrounds and fields of achievement. Since its establishment in 1979,the Revson Fellowship has welcomed over 260 leaders to the University.
The Christopher Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy.
Founded in 1979 by the late Mr. Noel Croucher, one of the founders of the original Hong Kong Stock Exchange and who condributed to the development of Hong Kong for nearly seven decades, with the object to promote the standard of natural sciences, technology and medicine through education and research activities in Hong Kong.
The Dana Foundation is a private philanthropic foundation with principal interests in science, health, and education. Charles A. Dana, a New York State legislator, industrialist, and philanthropist, founded what is today the Dana Corporation. He was president of the Dana Foundation from 1950 to 1966 and actively shaped its programs and principles until his death in 1975. His abiding beliefs were in the capacity and responsibility of individuals to shape and advance their lives and in the singular role of philanthropy in helping them to do so.
In January 1995, The EJLB Foundation established a Scholar Research Programme in order to provide outstanding young researchers with an opportunity to launch their scientific careers.
Established in 1966, the Fellowships Programme has gained an excellent reputation due to its rigorous selection process. The success of the programme is due the excellent involvement from the Fellowship Committee, EMBO members and Young Investigators who volunteer each year to assess candidates and proposals. Through the international exchange of persons, knowledge and skills in life science research a new network of scientists has been formed and the EMBO family expanded.
The mission of Fight for Sight is to support vision research to find the causes and cures for blindness and to help save the sight of children through support of pediatric eye centers.
The Foundation for the National Institutes of Health was established by the United States Congress to support the mission of the National Institutes of Health (NIH): improving health through scientific discovery. Guided by a board of directors composed of distinguished leaders in biomedical research, philanthropy, and business, the Foundation for NIH works to advance research by linking the generosity of private sector donors and partners to NIH programs.
The Foundation makes grants for charitable activity which it hopes may make life better for people, especially those who are disadvantaged.
The G. Harold & Leila Y. Mathers Foundation is primarily interested in supporting fundamental basic research in the life sciences. Support is provided for specific projects from established researchers at top universities and independent research institutions within the United States.
Goldman Philanthropic Partnerships, a private operating foundation, was founded in 1998 to establish a new philanthropic business model to accelerate the way cures are discovered.
This business model has created innovative research funding partnerships between donors, researchers and medical institutions using five tools unique to our foundation.The Helen Hay Whitney Foundation was established and endowed by Mrs.Charles S. Payson, the former Joan Whitney, in 1943, and named in honor of her mother, Helen Hay Whitney. Originally established to stimulate and support research in the area of rheumatic fever and rheumatic heart disease, the Foundation later expanded its interests to include diseases of connective tissue and, ultimately, all basic biomedical sciences.
Through its grants to individuals and institutions, HHMI supports the efforts of scientists and educators, colleges and universities, museums, and biomedical research organizations. These grants are transforming the ways research is conducted and science is taught and understood.
Research grants are provided for teams of scientists from different countries who wish to combine their expertise to approach questions that could not be answered by individual laboratories.
Emphasis is placed on novel collaborations that bring together scientist from different disciplines (e.g. from chemistry, physics, computer science, engineering) to focus on problems in the life sciences.Founded in 1950 by aerospace pioneer James S. McDonnell, the Foundation was established to "improve the quality of life," and does so by contributing to the generation of new knowledge through its support of research and scholarship. The Foundation awards grants via the Foundation-initiated, peer-reviewed proposal processes described in the 21st Century Science Initiative.
Johnson & Johnson, through its operating companies, is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than Johnson & Johnson operating companies employ approximately men and women in countries and sell products throughout the world.
The W.M. Keck Foundation makes grants to research institutions and accredited institutions of higher learning primarily in the areas of Science and Engineering, Medical Research and Liberal Arts. Eligible institutions in these fields are U.S.accredited universities, colleges, medical schools and major, independent scientific and medical research institutions.
The purpose ofthese awards is to support, in the early stages of their careers, young investigatorsengaged in basic or clinical research that may lead to a better understanding of epilepsy.
In addition to its major program interest in neuroscience, The Esther A. & Joseph Klingenstein Fund also devotes a majority of its resources to independent school education. Major support continues through programs of the Klingenstein Center for Independent School Education at Teachers College, Columbia University.
The McKnight Endowment Fund for Neuroscience works to bring science closer to the day when diseases of the brain and behavior can be accurately diagnosed, prevented, and treated.
The Merck Company Foundation is a US-based, private charitable foundation. Established in 1957 by Merck & Co., Inc., the Foundation is funded entirely by the Company and is Merck's chief source of funding support to qualified non-profit, charitable organizations. The mission of the Foundationis to support organizations and innovative programs in alignment with the four strategic priorities outlined below. The Merck Company Foundation supports initiatives that address societal needs and are consistent with our overall mission to enhance the health and well-being of people around the world.
MDA supports research aimed at developing treatments for the muscular dystrophies and related diseases of the neuromuscular system. These are the muscular dystrophies (among which are Duchenne and Becker); motor neuron diseases (including ALS and SMA); the peripheral nerve disorders (CMT and Friedreich's ataxia); inflammatory myopathies; disorders of the neuromuscular junction; metabolic diseases of muscle as well as other myopathies.
In its eleven-year history, NAAR has had a significant impact on autism research, committing nearly $37 million to fund over 270 autism research projects, fellowships, and collaborative programs worldwide. In 2006, Autism Speaks has already awarded 62 research grants, totaling $6.8 million dollars.This funding includes support for the Autism Tissue Program and research partnerships with the National Institutes of Health (NIH). Our goal is to identify and support promising research in the hope that results from these efforts will produce significant results reported in peer-reviewed journals, and additional research support from government or other funding agencies.
NARSAD invests in the best and brightest scientific minds throughout the world to unravel the complexities of schizophrenia, depression, anxiety and many other psychiatric diseases. Then, NARSAD continues to support the researchers as they use their findings to develop the next-generation of diagnostics and treatments for these conditions. With enough effort, NARSAD expects scientists someday to discover preventions and cures for these devastating illnesses.
The ALS Association is the only national not-for-profit health organization dedicated solely to the fight against ALS. ALSA covers all the bases - research, patient and community services, public education, and advocacy - in providing help and hope to those facing the disease. The mission of The ALS Association (ALSA) is to find a cure for and improve living with amyotrophiclateral sclerosis.
The mission of the NIEHS is to reduce the burden of human illness and disability by understanding how the environment influences the development and progression of human disease. To have the greatest impact on preventing disease and improving human health, the NIEHS focuses on basic science, disease-oriented research, global environmental health, and multidisciplinary training for researchers.
NIH is the nation's medical research agency – making important medical discoveries that improve health and save lives.
The NIH, a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research.The mission of NINDS is to reduce the burden of neurological disease - a burden borne by every age group, by every segment of society, by people all over the world.
NYSTAR funds world-class university/industry partnerships and promotes outstanding high-technology research and commercialization efforts that contribute to New York's economy.
The Southern Consortium for Injury Biomechanics brings together top scientists from several of the nation's prestigious universities, government and the private sectors to conduct collaborative research projects.
The SMA Foundation has pledged over $30M to the support of basic, translational and clinical research that will accelerate progress towards a treatment for SMA in the near term.
The Vision of Children Foundation’s mission is to cure hereditary childhood blindness and vision disorders, and to improve the quality of life of visually impaired individuals and their families. It advances towards this goal by directing and sponsoring scientific research leading to the prevention and treatment of these conditions, and by serving as an information source for the medical community, the public, and families affected by genetic vision disorders.
The Wellcome Trust is an independent charity funding research to improve human and animal health.
The Alzheimer’s Association, the world leader in Alzheimer research and support, is the first and largest voluntary health organization dedicated to finding prevention methods, treatments and an eventual cure for Alzheimer’s.
The Whitehall Foundation is a not-for-profit corporation which is focused exclusively on assisting basic research in vertebrate (excluding clinical) and invertebrate neurobiology in the United States.
The American Academy of Neurology (AAN) provides valuable resources for medical specialists world wide who are committed to improving the care of patients with neurological diseases. The AAN’s more than 19,000 members look to the AAN for the most comprehensive professional development, career enhancement, and practice improvement opportunities available.
The American Foundation for Suicide Prevention (AFSP) is the only national not-for-profit organization exclusively dedicated to understanding and preventing suicide through research and education, and to reaching out to people with mood disorders and those affected by suicide.
The American Heart Association is a national voluntary health agency whose mission is to reduce disability and death from cardiovascular diseases and stroke.
In the simplest terms, the mission of The Healing Exchange BRAIN TRUST is to improve quality of life for people living with brain tumors and related conditions.






































